Trial record 1 of 1 for:    NCT01901172
Previous Study | Return to List | Next Study

A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole and of the Relative Bioavailability of New Formulations of RO5503781 in Patients With Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Hoffmann-La Roche
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche
ClinicalTrials.gov Identifier:
NCT01901172
First received: July 9, 2013
Last updated: October 13, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)